SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$11.33
Tradestie Score
63
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+186.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.39
|
$2.44B | - | 68 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$75.46
|
$2.42B | - | 61 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$162.98
|
$2.41B | - | 49 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.81
|
$2.40B | - | 64 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.29
|
$2.37B | 120.1 | 53 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$9.28
|
$2.34B | - | 38 | Compare |
More SLS Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry